HK2 and brain cancer: Up-regulation of MCT1 contributes to the glycolytic phenotype of brain cancer cells, which was supported by the observed increase in glucose consumption and lactate production, as well as overexpression of GLUT1 and HKII in SW1088 cells in hypoxia.